ES2065908T3 - Composicion para la profilaxis y tratamiento de neumonia por "pneumocystis carinii". - Google Patents

Composicion para la profilaxis y tratamiento de neumonia por "pneumocystis carinii".

Info

Publication number
ES2065908T3
ES2065908T3 ES88302521T ES88302521T ES2065908T3 ES 2065908 T3 ES2065908 T3 ES 2065908T3 ES 88302521 T ES88302521 T ES 88302521T ES 88302521 T ES88302521 T ES 88302521T ES 2065908 T3 ES2065908 T3 ES 2065908T3
Authority
ES
Spain
Prior art keywords
prophylaxis
treatment
composition
pneumocystis carinii
pneumonia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88302521T
Other languages
English (en)
Inventor
Edward M Bernard
Donald Armstrong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memorial Sloan Kettering Cancer Center filed Critical Memorial Sloan Kettering Cancer Center
Application granted granted Critical
Publication of ES2065908T3 publication Critical patent/ES2065908T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION PARA LA PROFILAXIS O EL TRATAMIENTO DE LA NEUMONIA POR PNEUMOCYSTIS CARINII QUE CONSISTE EN UNA PULVERIZACION AEROSOL DE PENTAMIDA O UNA SAL FARMACOLOGICAMENTE ACEPTABLE DE LA MISMA, LA CUAL CONTIENE CANTIDADES IMPORTANTES DE PARTICULAS QUE TIENEN UN DIAMETRO AERODINAMICO EN LA GAMA DE 0,5 A 8,0 MICRAS.
ES88302521T 1987-03-26 1988-03-23 Composicion para la profilaxis y tratamiento de neumonia por "pneumocystis carinii". Expired - Lifetime ES2065908T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3087387A 1987-03-26 1987-03-26
US16256288A 1988-03-01 1988-03-01

Publications (1)

Publication Number Publication Date
ES2065908T3 true ES2065908T3 (es) 1995-03-01

Family

ID=26706546

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88302521T Expired - Lifetime ES2065908T3 (es) 1987-03-26 1988-03-23 Composicion para la profilaxis y tratamiento de neumonia por "pneumocystis carinii".

Country Status (10)

Country Link
EP (1) EP0292100B1 (es)
JP (1) JPH01228912A (es)
AT (1) ATE116847T1 (es)
AU (1) AU620025B2 (es)
CA (1) CA1334577C (es)
DE (1) DE3852717T2 (es)
DK (1) DK164788A (es)
ES (1) ES2065908T3 (es)
GR (1) GR3015412T3 (es)
IE (1) IE66819B1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3872635T2 (de) * 1987-04-09 1992-12-17 Fisons Plc Pentamidin enthaltende pharmazeutische zusammensetzungen.
US5204113A (en) * 1987-04-09 1993-04-20 Fisons Plc Pharmaceutical compositions containing pentamidine
IN168530B (es) * 1987-11-06 1991-04-20 Lyphomed Inc
US5366726A (en) * 1987-12-23 1994-11-22 The Regents Of The University Of California Suppression of Pneumocystis carinii using aerosolized pentamidine treatment
US4853416A (en) * 1988-04-25 1989-08-01 Fisons Corporation Solutions of pentamidine
GB8903438D0 (en) * 1989-02-15 1989-04-05 May & Baker Ltd New compositions of matter
ATE223202T1 (de) * 1994-09-30 2002-09-15 Mika Pharma Ges Fuer Die Entwi Pharmazeutische zusammensetzung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3533494A1 (de) * 1985-09-17 1987-03-19 Meyer Glauner Wilhelm Dr Aerosol-anwendung von pentamidin (p,p'-(pentamethylen-dioxy)-dibenzamidin-bis(ss-hydroxyethansulfonat) zur behandlung der durch pneumocystis carinii bedingten lungenentzuendung

Also Published As

Publication number Publication date
DE3852717D1 (de) 1995-02-23
DE3852717T2 (de) 1995-05-18
DK164788A (da) 1988-09-27
IE880913L (en) 1988-09-26
AU1331788A (en) 1988-09-29
AU620025B2 (en) 1992-02-13
EP0292100A1 (en) 1988-11-23
EP0292100B1 (en) 1995-01-11
GR3015412T3 (en) 1995-06-30
CA1334577C (en) 1995-02-28
ATE116847T1 (de) 1995-01-15
DK164788D0 (da) 1988-03-25
IE66819B1 (en) 1996-02-07
JPH01228912A (ja) 1989-09-12

Similar Documents

Publication Publication Date Title
ES2052682T3 (es) Una composicion farmaceutica potenciadora de la penetracion para aplicacion topica.
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
ES2119793T5 (es) Preparado topico que contiene una suspension de particulas lipidicas solidas.
MX165436B (es) Composiciones para el cuidado de la piel
ATE253941T1 (de) Zusammensetzung mit erhöhter lagerstabilität enthaltend cyclodextrin und wirkstoffe oder wirkstoff-vorstufen, die in wasserunlösliche komponenten zersetzt werden
ES2054069T3 (es) Composicion cosmetica o farmaceutica que contiene microesferas de polimeros o de cuerpos grasos cargados de al menos un producto activo.
ITMI910584A1 (it) Composizione farmaceutica idrofila contenente ketoprofene sale di lisina per uso topico.
MX18106A (es) Compuesto amidinicos y composiciones usadas para el tratamiento de pneumonia por pneumocystis carinii y otras enfermedades.
KR890000101A (ko) 반월조직의 치료 개선방법 및 치료약제
ATE72988T1 (de) Fettsaeure-zusammensetzungen.
MX173727B (es) Composicion farmaceutica oral con baja dosifica cion de inhibidor de plaquetas/anticoagulante
ES2065908T3 (es) Composicion para la profilaxis y tratamiento de neumonia por "pneumocystis carinii".
KR900014641A (ko) 동 및 동합금의 표면처리제
DE69308969D1 (de) Titansalz enthaltende, schweisshemmende Mittel und Zusammensetzung
DK0389035T3 (da) Farmaceutisk præparat der indeholder en farmaceutisk egnet bærer og forbindelsen med strukturen (7alfa,17alfa)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on
ES2052935T3 (es) Composicion topica.
ES2132112T3 (es) Producto de lavado con contenido reducido o nulo de ceolita.
PE33396A1 (es) Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
ES2107553T3 (es) Composiciones para el cuidado de la piel.
DK0666739T3 (da) Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
BR9805875A (pt) Composições farmacêuticas de droloxifeno.
ITPN920030A0 (it) Composizione per uso topico avente attivita' di stimolo per la ricrescita, di rinvigorimento, di prevenzione dell'ingrigimento e di ripigmentazione naturale dei capelli
NO891220D0 (no) Middel som inneholder salicylsyre for behandling av lepidose.
ES2089613T3 (es) Composicion detergente.
FR2525106B1 (fr) Composition cosmetique contenant en tant qu'agent actif sur l'elasticite et la souplesse de la peau, de la thiamorpholinone ou l'un de ses derives

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 292100

Country of ref document: ES